SCHOTT Pharma AG & Co. KGaA (1SXP XETRA) stock market data APIs
€19.4646
-0.44(-2.3%)
as of October 31, 2025
Try our APIs with
free plan!
SCHOTT Pharma AG & Co. KGaA Financial Data Overview
Price chart is built with
Anychart
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. The company also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products comprise Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Prev. Close
19.4646
Open
19.0268
High
19.7667
Low
19.0268
52 wk Range
18.5-30.25
Market Cap
2 925 M
P/E Ratio
20.0206
Shares Outstanding
151 M
Revenue
976 M
EPS
0.3
Dividends (Yield)
0.0082
Beta
1.109
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with SCHOTT Pharma AG & Co. KGaA (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SCHOTT Pharma AG & Co. KGaA data using free add-ons & libraries
Get SCHOTT Pharma AG & Co. KGaA Fundamental Data
SCHOTT Pharma AG & Co. KGaA Fundamental data includes:
- Net Revenue: 976 M
- EBITDA: 269 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 0.29
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SCHOTT Pharma AG & Co. KGaA News
New
What Does SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Share Price Indicate?
While SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) might not have the largest market cap around , it received a lot of attention from a substantial price movement on the XTRA over the last few months, incre...
Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
SCHOTT Pharma KGaA (ETR:1SXP) has had a rough three months with its share price down 28%. But if you pay close attention, you might gather that its strong financials could mean that the stock could po...
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
SCHOTT Pharma KGaA (ETR:1SXP) has had a rough three months with its share price down 5.4%. However, stock prices are usually driven by a company’s financial performance over the long term, which in ...
Analyst Estimates: Here's What Brokers Think Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) After Its First-Quarter Report
Last week saw the newest quarterly earnings release from SCHOTT Pharma AG & Co. KGaA (ETR:1SXP), an important milestone in the company's journey to build a stronger business. SCHOTT Pharma KGaA report...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
